About this episode

Dr. Omar Al Kalaa discusses the future of telesurgery and the challenges of remotely controlled medical systems in patient care.

Summary “FDA is still asking the same core question here: can the sponsor demonstrate that the full system is safe and effective for the patient?” In this episode of the Let’s Talk Risk Podcast , host Naveen Agarwal sits down with Dr. Omar Al Kalaa to talk about one of the most important emerging frontiers in MedTech: remotely controlled medical systems. From telesurgery to connected infusion therapy, these technologies are expanding what is possible in patient care—but they also introduce a very different kind of system risk. Omar brings a rare perspective at the intersection of medical devices and telecommunications. We explore why the real issue is not just connectivity, but control; why access to care is a major driver of these technologies; and why companies entering this space must think beyond the device itself to the broader ecosystem of networks, partners, responsibilities, and safeguards. Chapters 00:00 – Introduction 01:56 – What “remote control” really means in MedTech 04:36 – Telesurgery vs. interoperable connected care systems 08:30 – Why access to healthcare is driving adoption 11:31 – Connectivity failure modes and misunderstood telecom concepts 13:47 – What…

People in this episode

Host: Naveen Agarwal

Guest: Omar Al Kalaa

Topics covered

• telesurgery
• remotely controlled medical systems
• system risk
• connectivity
• access to care
• FDA engagement

Keywords

• telesurgery
• remotely controlled systems
• system risk
• connectivity
• FDA
• medical devices
• telecommunications

Mentioned in this episode

Organizations: FDA, MedTech, telecommunications

More episodes of Let's Talk Risk! with Dr. Naveen Agarwal

• LTR 151: Sarai Pahla on Managing Supply Chain Disruption Risk in Life Sciences · April 17, 2026 · 26 min
• Case Study: How Patient Preference Data Rescued a High-Risk Device · April 10, 2026 · 21 min
• LTR 150: Jonathan Kendler on Rethinking Human Factors Engineering for AI/ML-Enabled Devices · April 3, 2026 · 29 min
• LTR 149: Lavanya Ramnath on Risk Analysis, IDE Strategy, and Patient-Centered Design · March 27, 2026 · 29 min
• LTR 148: Chris Daly on Companion Diagnostics, AI, and FDA’s Evolving Approach · March 20, 2026 · 29 min
• LTR 147: Richard Matt on Bringing Benefit–Risk Upstream in Design and Development · March 13, 2026 · 27 min

Explore listener stats, chart rankings, contacts and more on the Let's Talk Risk! with Dr. Naveen Agarwal podcast page.